Johnson & Johnson (JNJ)
156.76
-1.42
(-0.90%)
USD |
NYSE |
Mar 18, 16:00
156.81
+0.05
(+0.03%)
Pre-Market: 20:00
Johnson & Johnson Total Assets (Quarterly): 167.56B for Dec. 31, 2023
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 167.56B |
September 30, 2023 | 166.06B |
June 30, 2023 | 191.69B |
March 31, 2023 | 195.97B |
December 31, 2022 | 187.38B |
September 30, 2022 | 175.12B |
June 30, 2022 | 177.72B |
March 31, 2022 | 178.36B |
December 31, 2021 | 182.02B |
September 30, 2021 | 179.23B |
June 30, 2021 | 176.44B |
March 31, 2021 | 172.56B |
December 31, 2020 | 174.89B |
September 30, 2020 | 170.69B |
June 30, 2020 | 158.38B |
March 31, 2020 | 155.02B |
December 31, 2019 | 157.73B |
September 30, 2019 | 155.52B |
June 30, 2019 | 155.12B |
March 31, 2019 | 150.03B |
December 31, 2018 | 152.95B |
September 30, 2018 | 155.70B |
June 30, 2018 | 155.36B |
March 31, 2018 | 156.62B |
December 31, 2017 | 157.30B |
Date | Value |
---|---|
September 30, 2017 | 155.66B |
June 30, 2017 | 152.81B |
March 31, 2017 | 144.92B |
December 31, 2016 | 141.21B |
September 30, 2016 | 140.37B |
June 30, 2016 | 139.81B |
March 31, 2016 | 136.23B |
December 31, 2015 | 133.41B |
September 30, 2015 | 133.27B |
June 30, 2015 | 132.04B |
March 31, 2015 | 128.59B |
December 31, 2014 | 130.36B |
September 30, 2014 | 132.10B |
June 30, 2014 | 135.20B |
March 31, 2014 | 133.33B |
December 31, 2013 | 132.68B |
September 30, 2013 | 126.93B |
June 30, 2013 | 124.32B |
March 31, 2013 | 121.54B |
December 31, 2012 | 121.35B |
September 30, 2012 | 118.95B |
June 30, 2012 | 115.75B |
March 31, 2012 | 116.19B |
December 31, 2011 | 113.64B |
September 30, 2011 | 111.82B |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
150.03B
Minimum
Mar 2019
195.97B
Maximum
Mar 2023
171.37B
Average
173.73B
Median
Total Assets (Quarterly) Benchmarks
Amgen Inc | 97.15B |
Gilead Sciences Inc | 62.12B |
Eli Lilly and Co | 64.01B |
Merck & Co Inc | 106.68B |
Moderna Inc | 18.43B |
Total Assets (Quarterly) Related Metrics
Total Liabilities (Quarterly) | 98.78B |
Shareholders Equity (Quarterly) | 68.77B |
Debt to Equity Ratio | 0.4265 |
Current Ratio | 1.156 |
Net Debt Paydown Yield | 0.14% |